StockData
10x Genomics, Inc. logo

10x Genomics, Inc. (TXG) stock

TXGNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 9/30106% above fair value
$56.30+1.31 (+2.38%)

Close on Nov 17, 2026Market cap $7.34BP/E –Yield –

10x Genomics cash

Cash and short-term investments held at the end of each period.

10x Genomics's cash was $575.68M at Sep 30, 2026. For fiscal 2025 it was $523.41M, up 33.0% from the year before. The highest annual figure on record is $688.64M in fiscal 2020.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$523.41M+33.0%
FY2024Dec 31, 2024$393.40M+1.2%
FY2023Dec 31, 2023$388.70M-11.2%
FY2022Dec 31, 2022$437.59M-26.6%
FY2021Dec 31, 2021$596.07M-13.4%
FY2020Dec 31, 2020$688.64M+44.5%
FY2019Dec 31, 2019$476.49M+579.8%
FY2018Dec 31, 2018$70.09M+46.5%
FY2017Dec 31, 2017$47.86M+14.6%
FY2016Dec 31, 2016$41.74M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$575.68M+19.4%
Q2 FY2026Jun 30, 2026$552.03M+23.4%
Q1 FY2026Mar 31, 2026$539.85M+26.5%
Q4 FY2025Dec 31, 2025$523.41M+33.0%
Q3 FY2025Sep 30, 2025$482.29M+21.1%
Q2 FY2025Jun 30, 2025$447.26M+17.7%
Q1 FY2025Mar 31, 2025$426.91M+14.8%
Q4 FY2024Dec 31, 2024$393.40M+1.2%
Q3 FY2024Sep 30, 2024$398.16M+10.5%
Q2 FY2024Jun 30, 2024$380.09M-4.1%
Q1 FY2024Mar 31, 2024$371.81M-12.7%
Q4 FY2023Dec 31, 2023$388.70M-11.2%
Q3 FY2023Sep 30, 2023$360.38M-21.7%
Q2 FY2023Jun 30, 2023$396.36M-21.9%
Q1 FY2023Mar 31, 2023$425.76M-22.2%
Q4 FY2022Dec 31, 2022$437.59M-26.6%
Q3 FY2022Sep 30, 2022$459.99M-24.5%
Q2 FY2022Jun 30, 2022$507.34M-21.8%
Q1 FY2022Mar 31, 2022$546.95M-15.1%
Q4 FY2021Dec 31, 2021$596.07M-13.4%
Q3 FY2021Sep 30, 2021$609.07M-26.9%
Q2 FY2021Jun 30, 2021$648.71M+60.7%
Q1 FY2021Mar 31, 2021$643.96M+49.1%
Q4 FY2020Dec 31, 2020$688.64M+44.5%
Q3 FY2020Sep 30, 2020$833.70M+74.6%
Q2 FY2020Jun 30, 2020$403.69M+561.3%
Q1 FY2020Mar 31, 2020$431.90M+508.7%
Q4 FY2019Dec 31, 2019$476.49M+579.8%
Q3 FY2019Sep 30, 2019$477.49M+442.2%
Q2 FY2019Jun 30, 2019$61.04M+27.6%
Q1 FY2019Mar 31, 2019$70.96M+70.0%
Q4 FY2018Dec 31, 2018$70.09M–
Q3 FY2018Sep 30, 2018$88.07M–
Q4 FY2017Dec 31, 2017$47.86M–
Q4 FY2016Dec 31, 2016$41.74M–

More 10x Genomics figures

See a number that looks wrong?